Search peptides, terms, sources/
Research source · 2015

Thymosin beta 4 ophthalmic solution for dry eye: a randomized, placebo-controlled, Phase II clinical trial conducted using the controlled adverse environment (CAE) model

About this source

Kind
Research
Design
RCT, Human clinical trial
Population
Human adults with moderate to severe dry eye, n=72, single centre, double-masked
Sample size
72
Primary or secondary
primary
Peer review
peer reviewed
Retraction status
None known
Date checked
14 November 2026

Limitations

Neither primary endpoint (ocular discomfort and inferior corneal staining at day 29) showed a significant difference between groups; the positive results were secondary measures. Single centre. Verified from the Europe PMC abstract record.

Cited in

Spotted an error? Report a problem with this page. We correct the record and log every change on What's changed.